Vir Biotechnology (VIR) Total Non-Current Liabilities (2018 - 2026)
Vir Biotechnology (VIR) recorded Total Non-Current Liabilities of $197.97 million in Q2 2026, down 6.4% from $211.44 million a year earlier but up 10.2% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology reported Total Non-Current Liabilities of $203.45 million, down 9.3% from FY2024.
- Annual Total Non-Current Liabilities has declined for three straight years, though with a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $224.38 million in FY2024 (-25.9%), $302.86 million in FY2023 (-56.7%), $699.19 million in FY2022 (+40.0%) and $499.6 million in FY2021 (+183.0%).
- Quarterly Total Non-Current Liabilities has ranged from $179.61 million in Q1 2026 to $867.22 million in Q1 2022 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined for four consecutive quarters, with an average decline of 13.1% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 215.8% in Q3 2021, against a decline of 67.4% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $179.61 million (Q1 2026), $203.45 million (Q4 2025) and $189.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Vir Biotechnology | 1.77 Bn | -185.85 Mn | 238.95 Mn | 179.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.10 Mn |
| Mar 31, 2026 | 160.19 Mn |
| Dec 31, 2025 | 181.87 Mn |
| Sep 30, 2025 | 175.87 Mn |
| Jun 30, 2025 | 198.41 Mn |
| Mar 31, 2025 | 225.46 Mn |
| Dec 31, 2024 | 209.80 Mn |
| Sep 30, 2024 | 210.57 Mn |
| Jun 30, 2024 | 191.43 Mn |
| Mar 31, 2024 | 204.77 Mn |
| Dec 31, 2023 | 287.08 Mn |
| Sep 30, 2023 | 332.38 Mn |
| Jun 30, 2023 | 396.65 Mn |
| Mar 31, 2023 | 663.21 Mn |
| Dec 31, 2022 | 688.07 Mn |
| Sep 30, 2022 | 508.24 Mn |
| Jun 30, 2022 | 630.93 Mn |
| Mar 31, 2022 | 859.48 Mn |
| Dec 31, 2021 | 491.36 Mn |
| Sep 30, 2021 | 309.40 Mn |
API Access
Vir Biotechnology Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();